-
Mashup Score: 9Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm - 2 year(s) ago
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 7Reversible Myocardial Edema Secondary to Tagraxofusp-Induced Capillary Leak Syndrome - 2 year(s) ago
Under a Creative Commons licenseOpen accessKey Wordsblastic plasmacytoid dendritic cell neoplasmcapillary leak syndromemyocardial edematagraxofuspAbbreviations and AcronymsBPDCNblastic plasmacytoid dendritic cell neoplasmCLScapillary leak syndromeCMRcardiovascular cardiac magnetic resonanceNT-proBNPN-terminal pro–B-type natriuretic peptideThe authors attest they are in compliance with human…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
#BPDCN 👉👉👉 Reversible Myocardial Edema Secondary to #Tagraxofusp-Induced Capillary... https://t.co/deNukyYnIq | #CLS #BPDCN @EMouhayar @DanielleHammo20 @doctorpemm @onco_cardiology @mkonople | @JACCJournals #CardioOnc #JACCCaseReports
-
-
Mashup Score: 1Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) - PubMed - 2 year(s) ago
Tagraxofusp has significantly improved the treatment landscape for patients with newly diagnosed BPDCN and has led to investigative efforts and augmentation of various strategies of targeting CD123, such as antibody-drug conjugates and anti-CD123 chimeric antigen receptor T-cells. However, relapsed/ …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm | Blood Advances | American Society of Hematology - 3 year(s) ago
Abstract. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and clinically challenging hematologic malignancy with dismal outcomes. With a median a
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Original Article from The New England Journal of Medicine — Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm - 3 year(s) ago
Journals & BooksRegisterSign inSign inRegisterJournals & BooksHelpAccess through your institutionto view subscribed content from homeAdvancedOutlineKeywordsKey pointsIntroductionLiterature reviewMechanism of actionPreclinical developmentClinical experience in adultsPediatric blastic plasmacytoid dendritic cell neoplasm: clinical experience in childrenContext for the early clinical experienceNext…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm | Blood Advances | American Society of Hematology - 4 year(s) ago
Abstract. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and clinically challenging hematologic malignancy with dismal outcomes. With a median
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm | Blood Advances | American Society of Hematology - 4 year(s) ago
Abstract. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and clinically challenging hematologic malignancy with dismal outcomes. With a median
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm - 4 year(s) ago
Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm. Expert Review of Anticancer Therapy. Accepted 6 May 2020.
Source: Taylor & FrancisCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 15Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm - 4 year(s) ago
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2020 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.ScienceDirect ® is a registered…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
👉👉👉Thrilled to see our paper Long-term outcomes of #Tagraxofusp in #BPDCN now out in print version @JCO_ASCO & 🙏🏾 for including on the cover of Sept 10,2022 issue! https://t.co/Hkil04BgnR | #CD123 @doctorpemm @mkonople @DrHKantarjian @lane_andy | @MDAndersonNews #endcancer https://t.co/j9mZRYCbUr